iRhythm Technologies, Inc. (IRTC)

Market Cap	3.66B
Revenue (ttm)	410.92M
Net Income (ttm)	-116.16M
Shares Out	30.22M
EPS (ttm)	-3.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	261,659
Open	118.64
Previous Close	119.23
Day's Range	117.57 - 121.55
52-Week Range	85.74 - 169.54
Beta	1.41
Analysts	Buy
Price Target	144.97 (+19.6%)
Earnings Date	May 4, 2023

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and E...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 1,700
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC

Financial Performance

In 2022, IRTC's revenue was $410.92 million, an increase of 27.29% compared to the previous year's $322.83 million. Losses were -$116.16 million, 14.6% more than in 2021.

Analyst Forecast

According to 17 analysts, the average rating for IRTC stock is "Buy." The 12-month stock price forecast is $144.97, which is an increase of 19.60% from the latest price.

Price Target

$144.97

(19.60% upside)

Analyst Consensus: Buy